Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Lucca

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pharmacology|September 1, 1993
Single-dose safety and pharmacokinetics of a potential cognition-enhancing compound, CL 275,838, in healthy volunteersS Caccia, S Confalonieri, G Guiso, et al.
Journal of Clinical Pharmacology|July 1, 1994
Multiple-dose pharmacokinetics and safety of a potential memory-enhancing compound, CL 275,838, in healthy male volunteersS Caccia, S Confalonieri, G Guiso, et al.
Neurology|November 1, 1991
Long-term acetyl-L-carnitine treatment in Alzheimer's diseaseA Spagnoli, U Lucca, G Menasce, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2010
Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptionsL Pasina, A Nobili, M Tettamanti, et al.
Journal of Clinical Pharmacy and Therapeutics|July 9, 2009
Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription databaseA Nobili, L Pasina, M Tettamanti, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesB Reisberg, L Schneider, R Doody, et al.
Dementia and Geriatric Cognitive Disorders|August 15, 2000
Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementiaT Rodriguez Martin, A M Calella, S Silva, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pharmacology|September 1, 1993
Single-dose safety and pharmacokinetics of a potential cognition-enhancing compound, CL 275,838, in healthy volunteersS Caccia, S Confalonieri, G Guiso, et al.
Journal of Clinical Pharmacology|July 1, 1994
Multiple-dose pharmacokinetics and safety of a potential memory-enhancing compound, CL 275,838, in healthy male volunteersS Caccia, S Confalonieri, G Guiso, et al.
Neurology|November 1, 1991
Long-term acetyl-L-carnitine treatment in Alzheimer's diseaseA Spagnoli, U Lucca, G Menasce, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2010
Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptionsL Pasina, A Nobili, M Tettamanti, et al.
Journal of Clinical Pharmacy and Therapeutics|July 9, 2009
Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription databaseA Nobili, L Pasina, M Tettamanti, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesB Reisberg, L Schneider, R Doody, et al.
Dementia and Geriatric Cognitive Disorders|August 15, 2000
Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementiaT Rodriguez Martin, A M Calella, S Silva, et al.
Pageof 2